BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Leukocyte, Neocentromeres, Prozac, rs2230926, BRCA1, T cell differentiation)
Bookmark Forward

QuickView for CTNNB1 (gene)


Body Atlas

Most Correlated Tissues

  1. Cerebellar vermis
  2. Endometrium
  3. Myometrium
  4. Cerebellum
  5. Ileum mucosa
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Hypoxia
  2. Liver cancer
  3. Bacterial pneumonia
  4. Skin cancer
  5. Poisoning by drug AND/OR medicinal substance
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. 2,3-dioxo-6-nitro-7-sulfamoylbenzo(f)quinoxaline
  2. Plasma Gases
  3. Argon
  4. Saquinavir
  5. 25-hydroxycholesterol
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR4717
  2. MIR142
  3. EIF2AK1
  4. ROR1
  5. MIR10A
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. WT1-Mutant Wilms Tumor Progression Is Associated With Diverting Clonal Mutations of CTNNB1.
  2. Wnt/β-Catenin Signaling in Oral Carcinogenesis.
  3. Clinicopathologic and Immunohistochemical Correlates of CTNNB1 Mutated Endometrial Endometrioid Carc…
  4. Exploration of CTNNB1 ctDNA as a putative biomarker for hepatoblastoma.
  5. β-Catenin mutations as determinants of hepatoblastoma phenotypes in mice.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation
  2. National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITU…
  3. Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive…
  4. Tailored Beta-catenin Mutational Approach in Extra-abdominal Sporadic Desmoids Tumor Patients
  5. Sunitinib as Second-line Treatment in Advanced Biliary Tract Carcinoma
Explore Clinical Trials Results
  • Copyright © 2021 Illumina Inc. All rights reserved.